Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Townsend

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 9, 2022
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug developmentKosalaram Goteti, Jonathan French, Ramon Garcia, et al.
Clinical Transplantation|February 10, 2017
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsT G Murali Dhar, Zhongqi Shen, Henry H Gu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survivalAndrew B Adams, Nozomu Shirasugi, Thomas R Jones, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of GlucocorticoidsYanhua Hu, Julie A Carman, Deborah Holloway, et al.
The Journal of Hospital Infection|July 7, 2026
Microbiological factors in the design, validation and verification of operating theatre ventilation: Healthcare Infection Society consensus guidance for infection prevention and control professionals, and members of ventilation safety groupsHilary Humphreys, Andrew M Thomas, Karren Staniforth, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analoguesT G Murali Dhar, Scott H Watterson, Ping Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive propertiesChristian P Larsen, Thomas C Pearson, Andrew B Adams, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2010
Five-year safety and efficacy of belatacept in renal transplantationFlavio Vincenti, Gilles Blancho, Antoine Durrbach, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
CPT: Pharmacometrics & Systems Pharmacology|November 9, 2022
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug developmentKosalaram Goteti, Jonathan French, Ramon Garcia, et al.
Clinical Transplantation|February 10, 2017
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsT G Murali Dhar, Zhongqi Shen, Henry H Gu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survivalAndrew B Adams, Nozomu Shirasugi, Thomas R Jones, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of GlucocorticoidsYanhua Hu, Julie A Carman, Deborah Holloway, et al.
The Journal of Hospital Infection|July 7, 2026
Microbiological factors in the design, validation and verification of operating theatre ventilation: Healthcare Infection Society consensus guidance for infection prevention and control professionals, and members of ventilation safety groupsHilary Humphreys, Andrew M Thomas, Karren Staniforth, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analoguesT G Murali Dhar, Scott H Watterson, Ping Chen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive propertiesChristian P Larsen, Thomas C Pearson, Andrew B Adams, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2010
Five-year safety and efficacy of belatacept in renal transplantationFlavio Vincenti, Gilles Blancho, Antoine Durrbach, et al.
Pageof 7